155 related articles for article (PubMed ID: 7920290)
1. HLA-DP and allogeneic bone marrow transplantation.
Moreau P; Cesbron A
Bone Marrow Transplant; 1994 Jun; 13(6):675-81. PubMed ID: 7920290
[TBL] [Abstract][Full Text] [Related]
2. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
4. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
Loiseau P; Espérou H; Busson M; Sghiri R; Tamouza R; Hilarius M; Raffoux C; Devergie A; Ribaud P; Socié G; Gluckman E; Charron D
Bone Marrow Transplant; 2002 Oct; 30(8):497-502. PubMed ID: 12379888
[TBL] [Abstract][Full Text] [Related]
5. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H
J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212
[TBL] [Abstract][Full Text] [Related]
6. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
7. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
[TBL] [Abstract][Full Text] [Related]
8. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
Gaschet J; Lim A; Liem L; Vivien R; Hallet MM; Harousseau JL; Even J; Goulmy E; Bonneville M; Milpied N; Vié H
J Clin Invest; 1996 Jul; 98(1):100-7. PubMed ID: 8690780
[TBL] [Abstract][Full Text] [Related]
9. HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants.
Kato Y; Mitsuishi Y; Cecka M; Hopfield J; Hunt L; Champlin R; Terasaki PI; Gajewski JL
Transplantation; 1991 Aug; 52(2):374-6. PubMed ID: 1871811
[No Abstract] [Full Text] [Related]
10. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
[TBL] [Abstract][Full Text] [Related]
11. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
13. New strategies for selection of unrelated bone marrow donors.
Martinelli G; Buzzi M; Farabegoli P; Testoni N; Mantovani V; Calori E; Rosti G; Bandini G; Bragliani M; Panzica G
Bone Marrow Transplant; 1993; 11 Suppl 1():31-2. PubMed ID: 8448542
[TBL] [Abstract][Full Text] [Related]
14. Histocompatibility and bone marrow transplantation (BMT).
Richter KV
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):445-50. PubMed ID: 2480287
[TBL] [Abstract][Full Text] [Related]
15. Measurement of recipient-specific alloreactivity: is GVHD predictable?
Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
[TBL] [Abstract][Full Text] [Related]
16. HLA-DP matching in allogeneic bone marrow transplantation.
Pawelec G; Ehninger G; Schmidt H; Rehbein A; Balko I; Wernet P
Transplant Proc; 1987 Feb; 19(1 Pt 3):2741-3. PubMed ID: 3274584
[No Abstract] [Full Text] [Related]
17. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
18. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors.
Martin PJ
Bone Marrow Transplant; 1991 Sep; 8(3):217-23. PubMed ID: 1958902
[TBL] [Abstract][Full Text] [Related]
19. Molecular techniques for typing unrelated marrow donors: potential impact of molecular typing disparity on donor selection.
Baxter-Lowe LA
Bone Marrow Transplant; 1994; 14 Suppl 4():S42-50. PubMed ID: 7728125
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical significance of HLA-DP patient-donor mismatches in allogeneic bone marrow transplantation.
Howell WM; Sage DA; Kohler JA; Darke C; Taylor GM
Bone Marrow Transplant; 1995 May; 15(5):816-7. PubMed ID: 7670416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
